Free Trial

Protara Therapeutics (TARA) SEC Filings & 10K Form

Protara Therapeutics logo
$3.90 -0.10 (-2.50%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$4.06 +0.16 (+3.97%)
As of 04/17/2025 06:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Protara Therapeutics SEC Filings

DateFilerForm TypeView
04/17/2025
3:05 PM
Nicacio Leonardo Viana (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/17/2025
3:10 PM
Nicacio Leonardo Viana (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
10:17 AM
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
Zummo Jacqueline (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/07/2025
11:58 AM
JANUS HENDERSON GROUP PLC (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
Form SCHEDULE 13G/A
03/05/2025
7:07 AM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2025
7:16 AM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2025
5:40 PM
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SCHEDULE 13G/A
02/14/2025
5:24 PM
CITADEL ADVISORS LLC (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
Form SCHEDULE 13G/A
02/14/2025
10:23 AM
JANUS HENDERSON GROUP PLC (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
Form SCHEDULE 13G
02/14/2025
5:31 AM
Opaleye Management Inc. (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
Form SCHEDULE 13G/A
02/12/2025
8:30 AM
Adage Capital Management, L.P. (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
Form SCHEDULE 13G
01/23/2025
3:05 PM
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Zummo Jacqueline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:05 PM
Fry Hannah (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:05 PM
Fabbio Patrick (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:05 PM
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Shefferman Jesse (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
3:34 PM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
3:20 PM
Fry Hannah (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:20 PM
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Zummo Jacqueline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:20 PM
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Shefferman Jesse (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
3:02 PM
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
Velan Capital Investment Management LP (Filed by)
Form SC 13G
12/11/2024
3:19 PM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2024
6:30 AM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 424B5
12/09/2024
3:17 PM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 424B5
12/05/2024
7:45 AM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
5:01 AM
Opaleye Management Inc. (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
Form SC 13G
11/14/2024
11:19 AM
CVI Investments, Inc. (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
Form SC 13G/A
09/12/2024
7:20 PM
Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
6:11 PM
Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2024
3:05 PM
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Shefferman Jesse (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:16 PM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/18/2024
3:05 PM
Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
6:56 PM
Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
1:00 PM
Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
5:45 PM
Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
5:00 PM
BESHAR LUKE M (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
5:00 PM
GARCEAU ROGER (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
5:00 PM
Huang Jane (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
5:00 PM
Levy Richard S (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
5:00 PM
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
SARGEN GREGORY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
5:00 PM
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Solomon Michael Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
5:00 PM
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Smith Cynthia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Now I look stupid. Real stupid... (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

06/10/2024
5:00 PM
Flannelly Barry P (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
6:01 PM
Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
6:48 PM
Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
5:57 PM
Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
11:15 PM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form EFFECT
05/02/2024
3:16 PM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/02/2024
7:05 AM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2024
7:10 AM
Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2024
7:43 PM
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:TARA) was last updated on 4/19/2025 by MarketBeat.com Staff
From Our Partners